Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females.

PloS one - 1 Jan 2023

Tariq Saba, Tariq Sundus, Abualhamael Shahad Abduljalil, Baig Mukhtiar, Malik Ahmad Azam, Shahzad Muhammad

Abstract excerpt

OBJECTIVES: The present study investigated osteoprotegerin (OPG) genetic polymorphisms and their influence on the therapeutic response to ibandronate in postmenopausal osteoporotic females. METHODS: This case-control study included 135 postmenopausal females (89 osteoporotic females and 46 non-osteoporotic females). Each osteoporotic patient received a monthly 150 mg ibandronate tablet for six months, and blood...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Diseases, Metabolic
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Osteoprotegerin

Share to Polymorphism, Single Nucleotide

Share to Postmenopause

Source

Open in PubMed Open full text

Identifiers

PMID: 37751449
DOI: 10.1371/journal.pone.0291959
PMCID: PMC10521989

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females.PMID 37751449Read ↗

Common Variants of the OPG gene Are Associated with Osteoporosis Risk: A Meta-Analysis.Semantic proximity Read ↗

Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis.Semantic proximity Read ↗

Association between osteoprotegerin genetic variants and osteoporosis in Chinese postmenopausal women.Semantic proximity Read ↗

Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women.Semantic proximity Read ↗

Association between osteoprotegerin genetic variants and bone mineral density in Chinese women.Semantic proximity Read ↗

The influence of osteoprotegerin genetic polymorphisms on bone mineral density and osteoporosis in Chinese postmenopausal women.Semantic proximity Read ↗

Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.Semantic proximity Read ↗

Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women.Semantic proximity Read ↗

Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women.Semantic proximity Read ↗

Significant associations between the A163G and G1181C polymorphisms of the osteoprotegerin gene and risk of osteoporosis, especially in postmenopausal women: a meta-analysis.Semantic proximity Read ↗

Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: Evidence via meta-analysis.Semantic proximity Read ↗

Influence of the Osteogenomic Profile in Response to Alendronate Therapy in Postmenopausal Women with Osteoporosis: A Retrospective Cohort StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.